REBEL Core Cast 85.0 – Superficial Venous Thrombosis
July 20, 2022
Take Home Points SVT >5cm or <3 cm from the SFJ should be treated with anti-coagulation. The rate of concurrent DVT and PE in patients...
Marco Torres
The Pragmatic Combination of YEARS Score and Age-Adjusted D-Dimer
January 24, 2022
Background: The optimal approach to risk stratifying patients for pulmonary embolism (PE) remains elusive. Multiple decision instruments are available with varying degrees of complexity and...
REBEL Cast Ep81: COVID-19, Thrombosis, and Anticoagulation
April 28, 2020
Early reports have shown that COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute VTE and exactly how to treat it...
LMWH in Cancer-Related VTE (CLOT Study)
September 20, 2018
Background: Venous thromboembolism (VTE) occurs frequently in patient with cancer. Treatment in this group entails a number of challenges including a higher rate of thrombosis...
Edoxaban in Cancer-Associated VTE
August 30, 2018
ACEP Clinical Policy on Acute VTE 2018
May 21, 2018
The evaluation and management of venous thromboembolism (VTE) in the Emergency Department (ED) is fraught with questions: who should I evaluate, who should get a...
Should I Stay or Should I Go: Outpatient Treatment of Venous Thromboembolism
December 5, 2016
Background: The care of venous thromboembolism (VTE) is currently undergoing a paradigm shift in the US with an increasingly large percentage of patients being discharged...
REBEL Cast Episode 16: Home Treatment of VTE with Rivaroxaban & RV Dilation on Bedside Echo
September 7, 2015
Welcome to the September 2015 REBELCast, where Swami, Matt, and I are going to tackle a couple of topics in the world of Venous Thromboembolism (VTE)....